- Home
- GTIM vs PASG Comparison
GTIM vs PASG Comparison
Compare GTIM & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTIM
- PASG
- Stock Information
- Founded
- GTIM 1987
- PASG 2017
- Country
- GTIM United States
- PASG United States
- Employees
- GTIM N/A
- PASG N/A
- Industry
- GTIM Restaurants
- PASG Biotechnology: Pharmaceutical Preparations
- Sector
- GTIM Consumer Discretionary
- PASG Health Care
- Exchange
- GTIM Nasdaq
- PASG Nasdaq
- Market Cap
- GTIM 17.1M
- PASG 20.3M
- IPO Year
- GTIM 1990
- PASG 2020
- Fundamental
- Price
- GTIM $1.73
- PASG $7.54
- Analyst Decision
- GTIM
- PASG Strong Buy
- Analyst Count
- GTIM 0
- PASG 4
- Target Price
- GTIM N/A
- PASG $59.25
- AVG Volume (30 Days)
- GTIM 34.5K
- PASG 37.5K
- Earning Date
- GTIM 08-07-2025
- PASG 08-12-2025
- Dividend Yield
- GTIM N/A
- PASG N/A
- EPS Growth
- GTIM 17.03
- PASG N/A
- EPS
- GTIM 0.12
- PASG N/A
- Revenue
- GTIM $143,398,000.00
- PASG N/A
- Revenue This Year
- GTIM N/A
- PASG N/A
- Revenue Next Year
- GTIM N/A
- PASG N/A
- P/E Ratio
- GTIM $15.40
- PASG N/A
- Revenue Growth
- GTIM 1.78
- PASG N/A
- 52 Week Low
- GTIM $1.34
- PASG $5.12
- 52 Week High
- GTIM $3.45
- PASG $26.60
- Technical
- Relative Strength Index (RSI)
- GTIM 59.37
- PASG 56.71
- Support Level
- GTIM $1.69
- PASG $6.65
- Resistance Level
- GTIM $1.84
- PASG $7.75
- Average True Range (ATR)
- GTIM 0.10
- PASG 0.69
- MACD
- GTIM 0.03
- PASG 0.21
- Stochastic Oscillator
- GTIM 78.00
- PASG 91.03
About GTIM Good Times Restaurants Inc.
Good Times Restaurants Inc is engaged in developing, owning, operating, and franchising hamburger-oriented drive-through restaurants. It operates through two segments: Good Times Burgers and Frozen Custard restaurants which operate in the quick-service drive-through dining industry; and Bad Daddy's Burger Bar restaurants which operate in the full-service upscale casual dining industry. The company generates maximum revenue from the Bad Daddy's Burger Bar restaurants segment. Its menu categories include burgers; chicken; frozen custard; slides and drinks.
About PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.